tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 858 are a BUY (93.46%), 57 are a HOLD (6.21%), 3 are a SELL (0.33%).
Analyst Raghuram Selvaraju, currently employed carries an average stock price target met ratio of 32.02% that have a potential upside of 49.63% achieved within 170 days. Previously, Raghuram Selvaraju worked at HC WAINWRIGHT.
Raghuram Selvaraju’s has documented 1,716 price targets and ratings displayed on 96 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on PCSA, Processa Pharmaceuticals at 05-Dec-2024.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for KZR (KEZAR LIFE SCIENCES) at 8/14/2024. The price target of $7 was fulfilled within 77 days with a profit of $6.39 (1047.54%) receiving and performance score of 136.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
1 years 1 months 1 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.04 (-0.99%)
300
Hold
$1
$-0.07 (-6.54%)
$5
1 years 1 months 26 days ago
(25-Oct-2023)
4/21 (19.05%)
$0.29 (40.85%)
32
Sell
$1
$-0.07 (-6.54%)
$3.5
1 years 5 months 2 days ago
(19-Jul-2023)
8/11 (72.73%)
$-0.08 (-7.41%)
55
Hold
$1.25
$0.18 (16.82%)
$2
1 years 5 months 2 days ago
(19-Jul-2023)
2/5 (40%)
$0.17 (15.74%)
215
Buy
$10
2 years 5 months 29 days ago
(22-Jun-2022)
13/47 (27.66%)
$6.81 (213.48%)
194
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
